insights_auto
Why is TNXP down 4,65%?
Dive Deeperchevron_right
TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
US$7,70
arrow_downward
-4,65%(-0,37) 1D
US$7,94
arrow_upward
+3,21% (+0,25)bedtimeAfter hours
Closed: 6 ຕ.ລ., 16 ໂມງ 0 ນາທີ 00 ວິນາທີ GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
US$8,15
High
US$8,33
Low
US$7,69
Mkt. cap
145,71 ລ້ານ
Avg. vol.
499,62 ພັນ
Volume
2,54 ລ້ານ
52-wk high
US$24,49
52-wk low
US$7,69
EPS
US$-12,92
Beta
1,78
Shares outstanding
17,15 ລ້ານ
No. of employees
142
Open
US$8,15
High
US$8,33
Low
US$7,69
Mkt. cap
145,71 ລ້ານ
Avg. vol.
499,62 ພັນ
Volume
2,54 ລ້ານ
52-wk high
US$24,49
52-wk low
US$7,69
EPS
US$-12,92
Beta
1,78
Shares outstanding
17,15 ລ້ານ
No. of employees
142
News stories
From web sources and news partners
Simply Wall Street
·
28 ນາທີກ່ອນ
How $950 Million Settlement Will Impact Roivant Sciences Stock (ROIV)
Moomoo
·
1 ຊົ່ວໂມງກ່ອນ
🏆 S&P 500 tops 7,800 for first time as tech rally defies surging yields
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, ນິວເຈີຊີ, ສະຫະລັດ
SectorBiotechnology
Websitetonixpharma.com